ArticleOpen heart2025

Sacubitril/valsartan is associated with improvements in quality of life in adult congenital heart disease patients with systemic right ventricular failure.

Ralph M L Neijenhuis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.